Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|15|2257-2262

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.15, 2011-05, pp. : 2257-2262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Interplay between Indoleamine 2,3-Dioxygenase 1 (IDO1) and Cyclooxygenase (COX)-2 In Chronic Inflammation and Cancer

By  

Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. : 2263-2271

Bentham Science Publishers

Access to resources Recommend Favorite

Indoleamine 2,3-dioxygenase, Tregs and Cancer

By  

Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. : 2240-2246

Bentham Science Publishers

Access to resources Recommend Favorite

PPARα as a therapeutic target in inflammation-associated diseases

By Gervois Philippe   Mansouri Roxane M  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1113-1125

Informa Healthcare

Access to resources Recommend Favorite

Proteases and their Receptors as Mediators of Inflammation-Associated Colon Cancer

By  

Current Pharmaceutical Design, Vol. 21, Iss. 21, 2015-06 ,pp. : 2983-2992

Bentham Science Publishers

Access to resources Recommend Favorite

Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 1, 2007-02 ,pp. : 31-40

Bentham Science Publishers

Access to resources Recommend Favorite